Glutamine: Clinical Trials

37 trials of Glutamine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 completed, 8 terminated, 4 withdrawn, 2 not yet recruiting. 37 Phase 2, 6 Phase 3, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 237Completed 19, Terminated 8, Withdrawn 4, Not yet recruiting 2, Recruiting 2, Unknown 2
Phase 36Completed 4, Terminated 1, Unknown 1
Phase 14Completed 2, Terminated 1, Withdrawn 1

Follow Glutamine: new trials by email Literature Review of Glutamine trials Research Report on Glutamine

Trials (filtered) newest first · largest first

All 37 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial of First-line Gemcitabine and Nab-paclitaxel With or Without L-glutamine in Advanced Pancreatic Cancer
Gemcitabine (1000 mg/m2), Nab-paclitaxel, L-glutamine - Pancreatic Cancer
Phase 2Not yet recruitingJun Gong, MD2002026-12-012026-10-08
A Randomized Controlled Trial of Five - Flavor Sophora Flavescens Enteric - Coated Capsules for Radiation - Induced Proctitis After Pelvic Radiotherapy
five - flavor sophora flavescens enteric - coated capsules plus glutamine and warm - water sitz baths, glutamine and warm - water sitz baths - Radiation - Induced Proctitis
Phase 2Not yet recruitingPeking University First Hospital1242025-06-302025-07-08
Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury.
Thalidomide, Glutamine, Thalidomide+Glutamine - Radiation Enteritis
Phase 2RecruitingYongquan Shi1502024-09-302026-03-27
Effect of L-Glutamine on Pulmonary Artery Pressure in Patients With Non-Transfusion-Dependent Thalassemia
L-glutamine - Pulmonary Artery Pressure, Thalassemia
Phase 2 / Phase 3CompletedMazandaran University of Medical Sciences82023-08-152025-10-07
A Study of Glutamine to Treat Intestinal Permeability in Functional Dyspepsia
Glutamine, Placebo - Functional Dyspepsia
Phase 1 / Phase 2CompletedDavid J. Cangemi122023-02-162026-02-03
Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)
Alanyl-glutamine - Clostridioides Difficile Infection, Clostridium Difficile Infection
Phase 2RecruitingUniversity of Virginia2602021-06-012024-10-26
Treatment of Adults With Generalized Anxiety Disorder Using Glutamine
L Glutamine, Placebos - Generalized Anxiety Disorder
Phase 2TerminatedHospital Universitario Dr. Jose E. Gonzalez382019-01-182021-02-11
A Cohort Study of Beta-Glucan or Beta-Glucan Compound in Metastatic Cancers
Beta-Glucan, Glutamine, Immunoglobuin - Metastatic Cancer, Chemotherapy
Phase 2 / Phase 3UnknownE-DA Hospital902018-01-042021-01-25
Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Lymphoma
Palifermin, Panobinostat, Gemcitabine - Lymphoma
Phase 2WithdrawnM.D. Anderson Cancer Center2017-06-012017-04-21
Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype
Lenalidomide, Vorinostat, Gemcitabine - Lymphoma
Phase 1 / Phase 2TerminatedM.D. Anderson Cancer Center82016-06-222019-12-13
Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma
Busulfan, Caphosol, Glutamine - Lymphoma
Phase 1 / Phase 2WithdrawnM.D. Anderson Cancer Center2016-06-012016-05-04
Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma
Carfilzomib, SAHA, Gemcitabine - Myeloma
Phase 2WithdrawnM.D. Anderson Cancer Center2014-09-012014-07-11
Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy
Glutamine, Placebo - Breast Cancer
Phase 2TerminatedUniversity of Arkansas142014-06-012019-05-29
Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation
Standard of care ADT + (HMB + arginine + glutamine), Standard of care ADT - Prostate Cancer
Phase 2CompletedMedical College of Wisconsin482014-03-012023-09-22
Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma
Azacitidine, Vorinostat, Gemcitabine - Advanced Cancers, Lymphoma
Phase 1 / Phase 2CompletedM.D. Anderson Cancer Center612013-11-072020-01-27
Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib
glutamine, quality-of-life assessment, placebo - Chemotherapeutic Agent Toxicity, Multiple Myeloma
Phase 2TerminatedBeth Faiman92013-02-012019-10-22
Validity Study of Glutamine to Improve Cardiac Function in Cardiac Surgery
Glutamine, Ringer's solution - Rheumatic Heart Disease, Coronary Heart Disease
Phase 2CompletedYuejiang Liu332013-01-012014-05-28
Safety of Gastric Volume Emptying After the Intake of Maltodextrin and Glutamine
Maltodextrin, Glutamine - Pulmonary Aspiration of Gastric Contents, Adverse Effects in the Therapeutic Use of Other and Unspecified General Anaesthetics
Phase 2CompletedFederal University of Mato Grosso112012-03-012013-02-25
Supplementation of Glutamine and Fish Oil Versus Placebo in Patients With Heart Failure
Glutamine and Fish Oil Supplementation, Placebo - Heart Failure
Phase 2 / Phase 3CompletedColumbia University312011-11-012020-12-22
A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin
Glutamine - Colorectal Carcinoma, Neoplasms, Colorectal
Phase 2WithdrawnAHS Cancer Control Alberta2011-10-012016-02-24

Showing 20 of 37. Sign in to see all of them.

Conditions studied

Lymphoma (5)  ·  Anemia, Sickle Cell (4)  ·  Thalassemia (4)  ·  Lymphoma, Large B-Cell, Diffuse (3)  ·  Colorectal Neoplasms (2)  ·  Multiple Myeloma (2)  ·  Muscular Dystrophy, Duchenne (2)  ·  Neoplasm Metastasis (2)  ·  Peripheral Nervous System Diseases (2)  ·  Sepsis (2)  ·  Breast Neoplasms (1)  ·  Burkitt Lymphoma (1)  ·  Clostridium Infections (1)  ·  Coronary Disease (1)  ·  Critical Illness (1)

Sponsors

M.D. Anderson Cancer Center (5)  ·  AHS Cancer Control Alberta (2)  ·  Columbia University (2)  ·  Ain Shams University (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Beth Faiman (1)  ·  Christiana Care Health Services (1)  ·  Cooperative International Neuromuscular Research Group (1)  ·  David J. Cangemi (1)  ·  E-DA Hospital (1)  ·  Emmaus Medical, Inc. (1)  ·  Emory University (1)  ·  Federal University of Mato Grosso (1)  ·  Hospital Universitari Son Dureta (1)  ·  Hospital Universitario Dr. Jose E. Gonzalez (1)

Countries

United States (21)  ·  China (2)  ·  Brazil (1)  ·  Canada (1)  ·  Egypt (1)  ·  France (1)  ·  Iran (1)  ·  Mexico (1)  ·  Spain (1)  ·  Taiwan (1)

Top investigators

Yago Nieto, MD, PHD (4)  ·  Michael Sawyer, MD (2)  ·  Yutaka Niihara, MD (2)  ·  Augusta Saulys, MD (1)  ·  Barbara Jean Bambach, MD (1)  ·  Beth Faiman (1)  ·  Claudia Morris, MD (1)  ·  David Cangemi, MD (1)  ·  Diana M Escolar, MD (1)  ·  GHada A. Saleh, MRCPCH (1)  ·  Gunnar Buyse, MD, PhD (1)  ·  Julia L. Glade-Bender, MD (1)  ·  Jun Gong, MD (1)  ·  Kathryn Bylow, MD (1)

Results publications

PMID 15984021, PMID 16086046, PMID 17636753, PMID 19421321, PMID 22261571, PMID 25861285, PMID 26269566, PMID 29392418, PMID 30108163, PMID 37474181, PMID 38775255

NIH funding

P50AT000076 (1)